Brussels, often cited as the "Pharma Capital of Europe," represents a critical nexus for biopharmaceutical innovation. As home to the Brussels South Charleroi Biopark and numerous global healthcare headquarters, the region demands the highest standards in sterile fluid handling. Bio-process Liquid Transfer Assemblies are the vascular system of this industry, ensuring that life-saving biologics, vaccines, and cell therapies move through production lines without the risk of contamination.
Our presence as a key exporter to Brussels is driven by the region's shift toward Single-Use Systems (SUS). Unlike traditional stainless-steel setups, our customized assemblies provide Brussels' labs and factories with the flexibility to pivot between different drug batches rapidly, reducing cleaning validation times by up to 60% and significantly lowering capital expenditure.
ISO Class 7 cleanroom manufacturing ensures zero-particulate fluid pathways for Brussels' strict regulatory environment.
Modular designs featuring C-Flex®, silicone tubing, and sterile connectors tailored for local Belgian R&D needs.
Direct supply chain from Changzhou to Zaventem Airport, ensuring lead times are cut by 30% compared to local middle-men.
The bioprocessing landscape in Brussels is evolving toward Industry 4.0. Our technical roadmap for liquid transfer assemblies integrates several breakthrough technologies:
As an exporter, we are not just providing hardware; we are providing a future-proof technical bridge between China's manufacturing efficiency and Europe's innovative bioprocessing demands.
Changzhou U-Care Medical Co., Ltd. sits at the heart of the Yangtze River Delta, a region unparalleled in its industrial vertical integration. This location allows us to source raw medical-grade polymers, precision-mold connectors, and execute gamma sterilization within a 50-mile radius. For our Brussels clients, this translates to unmatched supply chain resilience.
During global logistical disruptions, our diversified shipping routes—utilizing both air freight to Brussels (BRU) and rail options via the New Silk Road—ensure that critical bioprocessing projects never face a "stock-out" situation. Our factory’s 24/7 production capability ensures that we can scale from a pilot-study manifold to full-scale commercial production assemblies in a fraction of the time required by traditional European manufacturers.
Changzhou U-Care Medical Co., Ltd. was established in 2014 and is located in Changzhou, Jiangsu Province, within the core region of the Yangtze River Delta—one of China’s most dynamic and economically advanced areas. Benefiting from a strategic location and convenient transportation network, the company enjoys strong access to both domestic and international markets.
U-Care Medical has accumulated extensive experience in the manufacturing of medical and pharmaceutical packaging products. The company is dedicated to the research, development, and production of high-quality disposable medical and pharmaceutical packaging materials. With a focus on innovation and reliability, U-Care strives to provide safe, efficient, and customized solutions to meet the evolving needs of healthcare and pharmaceutical industries worldwide.
The company is equipped with modern production facilities and adheres strictly to industry standards and quality management systems. From raw material selection to final product delivery, every step is carefully controlled to ensure product consistency, safety, and compliance with international regulations.
We always place product quality at the highest priority. Customer satisfaction is the driving force behind our continuous improvement and development.
We are committed to building long-term partnerships with our clients by adhering to honest and transparent business practices.
To become a trusted global provider of medical and pharmaceutical packaging solutions by consistently delivering superior quality.
We use medical-grade, USP Class VI certified materials including Platinum-cured Silicone, C-Flex®, and various fluoropolymers. Each assembly is designed to minimize extractables and leachables, ensuring the purity of your biopharma products.
Yes, all our bio-process assemblies can be provided gamma-irradiated (typically 25-45 kGy) with a full certificate of sterility. We adhere to ISO 11137 standards to meet European CE and Belgian regulatory requirements.
Absolutely. We design bespoke manifolds and transfer lines compatible with all major bioreactor systems used in Brussels' labs, including Sartorius, Thermo Fisher, and Cytiva systems.
Standard custom designs are prototyped within 1-2 weeks. After approval, bulk production and air freight to Brussels typically take an additional 2-3 weeks, providing a much faster turnaround than many domestic EU suppliers.